Full-Time

Executive Assistant

Ceo

Confirmed live in the last 24 hours

Cytokinetics

Cytokinetics

501-1,000 employees

Develops drugs for muscle function disorders

Biotechnology
Healthcare

Compensation Overview

$144k - $160kAnnually

Senior, Expert

San Bruno, CA, USA

Employee must be onsite at our South San Francisco location 5 days per week.

Category
Executive Support
Administrative & Executive Assistance
Required Skills
Word/Pages/Docs
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides

You match the following Cytokinetics's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Bachelor’s degree is preferred
  • 10+ years executive level administrative experience with at least 5+ years supporting a CEO and other senior leadership team members in the biotech industry
  • Direct experience interfacing with Board members, bankers, analysts and investors a plus
  • Proven ability to exercise discretion and confidentiality with sensitive company information
  • Strong sense of urgency and ownership, with the ability to thrive in a fast-paced and demanding environment
  • Exceptional organizational skills, with the ability to manage tight deadlines and handle multiple projects simultaneously
  • Excellent written and verbal communication skills, with the ability to effectively communicate and partner with all levels of the organization and external parties (e.g., board members, investors, partners, vendors)
  • Advanced computer skills, including proficiency in PowerPoint, Excel, Word, Outlook, Access or other database applications, video conferencing tools (e.g., Zoom, Teams, WebEx), expense reporting systems (e.g., Concur), and contract management systems.
Responsibilities
  • Deliver professional and high-level administrative support to the CEO, managing highly confidential information and sensitive contacts.
  • Efficiently manage the CEO’s calendar with precision, prioritizing and resolving schedule conflicts. Organize and manage logistics for meetings, including scheduling, room preparation, catering, and technology setup.
  • Arrange complex domestic and international travel itineraries and related meetings. Proactively manage pre-travel preparations, including agendas, necessary contacts, information, and other preparations. Handle expense reports timely and with accuracy.
  • Prepare complex and professional presentations for a variety of internal and external meetings. Ensure all materials are prepared and organized for company meetings and assist in the creation of content as needed.
  • Manage Board of Directors meetings, including agenda preparation, organizing board presentations, coordinating board travel and logistics, and overseeing budget management for off-site meetings and expense reporting.
  • Lead and manage various special projects as assigned by the CEO. This includes conducting research, compiling data, and preparing reports and documents.
  • Create and maintain organized files, records, contact lists, and databases to ensure the efficient operation of the CEO’s office. Implement and manage systems to improve efficiency and workflow.
  • This role requires the employee to be onsite at our South San Francisco location 5 days per week.
Desired Qualifications
  • Direct experience interfacing with Board members, bankers, analysts and investors a plus

Cytokinetics focuses on developing medicines that improve muscle function for patients with cardiovascular and neuromuscular diseases. Their products are small molecule drugs designed to either enhance or inhibit muscle function, tailored to specific therapeutic needs. The company has a pipeline of drugs, including omecamtiv mecarbil and reldesemtiv, which are in various stages of clinical trials. Unlike many competitors, Cytokinetics emphasizes rigorous scientific research and has conducted over 50 clinical trials to ensure the effectiveness of its treatments. The goal is to bring new therapies to market that address the unmet needs of patients suffering from conditions like heart failure, ALS, and HCM.

Company Size

501-1,000

Company Stage

IPO

Total Funding

$58.4M

Headquarters

South San Francisco, California

Founded

1998

Simplify Jobs

Simplify's Take

What believers are saying

  • Recent investments indicate strong interest in muscle activators and inhibitors.
  • Strategic partnerships, like with Sanofi, expand market reach and potential revenue.
  • Significant funding from Royalty Pharma supports commercial launch and R&D advancements.

What critics are saying

  • Increased competition could impact market share and profitability.
  • Potential delays in clinical trials could hinder drug commercialization.
  • Dependence on strategic partnerships may expose Cytokinetics to risks if challenges arise.

What makes Cytokinetics unique

  • Cytokinetics focuses on muscle activators and inhibitors for cardiovascular and neuromuscular diseases.
  • The company has a robust pipeline including omecamtiv mecarbil and aficamten.
  • Cytokinetics engages in strategic partnerships, like with Sanofi, to expand market reach.

Help us improve and share your feedback! Did you find this helpful?

Growth & Insights and Company News

Headcount

6 month growth

-1%

1 year growth

-5%

2 year growth

-2%
Stock Titan
Jan 6th, 2025
Cytokinetics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) - Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 9:00 AM Pacific Time in the Borgia Room of the Westin St. Francis Hotel in San Francisco, CA.

BioSpace
Dec 20th, 2024
Cytokinetics Announces Sanofi Acquired Rights to Develop and Commercialize Aficamten in Greater China

Cytokinetics announces Sanofi acquired rights to develop and commercialize Aficamten in Greater China.

MarketBeat
Nov 26th, 2024
Intech Investment Management LLC Invests $1.73 Million in Cytokinetics, Incorporated (NASDAQ:CYTK)

Intech Investment Management LLC invests $1.73 million in Cytokinetics, Incorporated (NASDAQ:CYTK).

MediaPost
Oct 11th, 2024
Cytokinetics Educates Docs On Non-Physical Ordeals Of Cardio Condition

Setting the stage for its first consumer product after 25 years as a biopharma development company, Cytokinetics has launched "HCM Beyond the Heart," an awareness campaign educating cardiologists and other healthcare professionals (HCP) about the personal burdens caused by hypertrophic cardiomyopathy (HCM), a leading cause of sudden cardiac death.

Business Directory 88
Aug 21st, 2024
Armistice Capital Performance: A Closer Look at Healthcare Investment Strategies

Armistice Capital has invested in Cytokinetics Incorporated, a late-stage biopharmaceutical organization investigating treatments for impaired muscle function-related cardiovascular and neuromuscular diseases.